A column-switching system with high-performance liquidchromatographic separation and ultraviolet detection is described for automated determination of fluvoxamine in human plasma or serum. Samples were injected and the drug was retained in a clean-up column [20 x 4.6 mm (i. 
vol) at a flow rate of 1.5 mL/min for <20 mm and detected by spectrometry at 214 nm. With oxaprotiline as internal standard, fluvoxamine could be easily quantified, and it was well separated from endogenous Therefore, the anticholinergic or antihistaminergic side effects of tricyclic antidepressants (7) (8) (9) valve and the analytical column. All columns were packed by and purchased from CTI (Konigstein, Taunus, FRG). The flow rate was 1.5 mLlmin. The eluents had been filtered through 0.22-sm pore-size filters and degassed by sonification before use. Sample clean-up and chromatographic separation were performed at room temperature.
Calculations
From the recorded peak areas, the ratios of drug to 
Results

Prepurification.
With C8 bonded silica material in the clean-up column, fluvoxamine was retained, while proteins, lipids, and various other plasma constituents were eluted to waste by water containing methanol, 50 mLIL. After switching to the acetonitrile:methanol: phosphate buffer eluent (577:188:235 by vol), fiuvoxamine was removed from the clean-up column in <2 mm and eluted in a distinct peak on the Nucleosil 100 CN analytical column (Figure 2) .
Other phases such as C18, phenyl, or cyanopropyl bonded silica could also be used instead of Hypersil MOS C8 in the clean-up column to retain fluvoxamine. The C5 material, however, was more stable, which was important for long-term use of the HPLC system. The inclusion of 10-pm particles of Hypersil MOS C8 enabled -100 plasma samples to be analyzed without any decrease in recovery rates (see below) and negligible increase in back pressure.
Chromatographic separation.
For optimal chromatographic separation, Nucleosil 100 CN was superior to 
Interferences.
When the experimental conditions that
were considered optimal for sample prepurification and drug retention were used for assaying blank plasma samples obtained from 10 nonmedicat.ed healthy volunteers, no significant interferences from endogenous constituents were observed (Figure 2 
Sensitivity.
Without modifications, the lower limit of detection was -10 pg/L (32 nmol/L). It could be easily decreased by increasing the plasma sample size loaded onto the clean-up column. When identical plasma samples were applied onto the clean-up column three times and each 100-pL injection was followed by a 15-mn 
